Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03542084 · ClinicalTrials.gov registry record · NA
Endocrinology Auto-Triggered e-Consults
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 305
- Enrollment target
NCT03542084: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03542084 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 305 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03542084, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 305 participants
- Enrollment target
Study Summary
Diabetes currently affects 25.8 million people in the U.S. Patients with diabetes are generally managed, at least initially, by a primary care practitioner (PCP). As the prevalence of diabetes continues to rise, PCPs are under increased pressure to achieve recommended glycemic targets. Failure to achieve these targets has been shown to increase clinical complications and cost of care. Endocrinology referral is common for those patients not meeting A1c goals. Unfortunately, access to specialty endocrinology care is limited and patients routinely wait weeks or months before being seen. Electronic consultation (e-consult) is a new and innovative delivery model that has the potential to provide greater access to specialty care. The current system at Massachusetts General Hospital (MGH) allows PCPs to electively place an e-consult to solicit specialist input. Specialists in turn review the patients chart, relevant data and the clinical question and respond within the electronic medical record. E-consults have been well received by both patients and physicians, not only at MGH, but also across many centers in the US. With that said, the e-consult system remains in its infancy and current literature largely focuses on process metrics without hard clinical end-points. One way to optimize care for patients with diabetes is to automatically trigger an endocrinology e-consult for those not meeting A1c targets. The goal of this project will be to conduct a rigorous scientific evaluation of auto-triggered e-consults across Massachusetts General Hospitals affiliated primary care practices. The e-consults will be unsolicited and triggered based on inclusion criteria that include a1c and date of last PCP visit. This project will leverage an existing diabetes population health registry that is being used currently for ongoing diabetes care initiatives.
Interventions
- OTHER Unsolicited endocrine e-consult
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 305 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2020-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03542084
The ClinicalTrials.gov registry entry for NCT03542084 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Unsolicited endocrine e-consult is the first listed.
NCT03542084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03542084 about?
NCT03542084 is a clinical study titled "Endocrinology Auto-Triggered e-Consults". Diabetes currently affects 25.8 million people in the U.S. Patients with diabetes are generally managed, at least initially, by a primary care practitioner (PCP). As the prevalence of diabetes continues to rise, PCPs are under increased pressure to achieve recommended glycemic targets. Failure to ac...
What is the current status of trial NCT03542084?
This trial is currently completed. It is a NA study. The enrollment target is 305 participants. The study started on 2018-09-04. Estimated completion is 2020-08-30.
What interventions are being tested in trial NCT03542084?
The interventions under investigation include: Unsolicited endocrine e-consult (OTHER).
Who is sponsoring clinical trial NCT03542084?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.